-+ 0.00%
-+ 0.00%
-+ 0.00%
Tsingke Bridges AI-Driven Molecular Design and Real-World Experimentation with Automated Manufacturing
Share
Listen to the news

BEIJING, Nov. 5, 2026 /PRNewswire/ -- Tsingke Biotech ("Tsingke"), a provider of nucleic acid and gene synthesis solutions, is advancing its "AI + Molecular Manufacturing" strategy by integrating scalable synthesis, high-throughput experimentation and laboratory automation to support data-driven molecular R&D.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending